Results 111 to 120 of about 2,397 (210)

Determination of the levels of brain natriuretic peptide and its N-terminal fragment for the evaluation of the efficiency of renal replacement therapy modalities in patients with decompensated chronic heart failure

Терапевтический архив, 2010
Aim: to compare the capabilities of identifying different types of brain natriuretic peptide (BNP) for the evaluation of renal replacement therapy modalities in patients with decompensated chronic heart failure (CHF). Subjects and methods.
E A Tabakyan, A Yu Zaruba, A N Rogoza, D M Ataullakhanova, V V Kukharchuk   +4 more
doaj  

Stability-indicating HPTLC method for analysis of torsemide in pharmaceutical preparations [PDF]

, 2011
Rajendra Kakde, Nirmal Chaudhary, Anup Barsagade, Dipak Kale   +3 more
openalex   +1 more source

A Life-Threatening Case of Torsemide-Induced Toxic Epidermal Necrolysis Associated With the Treatment of Anasarca [PDF]

, 2022
Sujana Reddy, Bray K Aron, John Stewart
openalex   +1 more source

Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure

, 2023
Selim R. Krim, Senthil Anand, Stephen J. Greene, Anqi Chen, Daniel Wojdyla, Juan Vilaro, Herbert Haught, John M. Herre, Eric L. Eisenstein, Kevin J. Anstrom, Bertram Pitt, Eric J. Velazquez, Robert J. Mentz   +12 more
openalex   +2 more sources

Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure – insights from TRANSFORM-HF

AimAmong patients discharged after hospitalization for heart failure (HF), a strategy of torsemide versus furosemide showed no difference in all-cause mortality or hospitalization. Clinicians have traditionally favoured torsemide in the setting of kidney
Martens, Pieter, Velazquez, Eric J., Ketema, Fassil, Anstrom, Kevin, Hall, Michael E., Greene, Stephen J., Li, Shuang, Fang, James C., Kim, Dong-Yun, Mentz, Robert J., Tang, W.H. Wilson, Kapelios, Chris J., Wojdyla, Daniel, Eisenstein, Eric L., Pitt, Bertram, Mullens, Wilfried   +15 more
core   +1 more source

Torsemide versus Furosemide Therapy in Patients with Chronic Heart Failure: An updated Meta-analysis [PDF]

Fahimeh Talaei, Rebecca Pratiti, Mahmoud M. Ibrahim, Khaled Almorsy, Varsha Moudgal, Kavitha Kesari   +5 more
openalex   +1 more source

Potential Advantages of Torsemide in Patients with Heart Failure: More than Just a ‘Water Pill’? [PDF]

, 2017
Stephen J. Greene, Robert J. Mentz
openalex   +1 more source

Diuretic Use in Heart Failure. [PDF]

Rev Cardiovasc Med
Nassar G, Jameson R.
europepmc   +1 more source

Therapeutics Letter 17

, 1997
Therapeutics Letter 17 reviews the five newer drugs famciclovir, valacyclovir, torsemide, etodolac, and naltrexone. Conclusions: Anti-viral drugs have a modest beneficial effect if given early (rash 50 yr) with moderate to severe rash or pain associated ...
Therapeutics Initiative (University of British Columbia)
core  

Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure

Juan Vilaro, Eric L. Eisenstein, Robert J. Mentz, Anqi Chen, John M. Herre, Eric J. Velazquez, Selim R. Krim, Herbert Haught, Kevin J. Anstrom, Stephen J. Greene, Senthil Anand, Bertram Pitt, Daniel Wojdyla   +12 more
openalex   +1 more source